10th European Conference on Clinical Neuroimaging March 2022 Geneva, Switzerland

INVITED SPEAKERS IN 2022



RONALD BOELLAARD

"Technological developments in PET design: whole body and dedicated systems" - March 14, 2022 at 9.30am

Prof.dr. Ronald Boellaard (M) is appointed as full professor at the Amsterdam University Medical Centers and at the University Medical Center Groningen, The Netherlands. He has a background in biology (MSc) and physics (MSc) and a PhD in science. His research focuses on (pharmacokinetic) quantitative analysis of positron emission tomography (PET), PET image reconstruction and processing. He is member of several international societies and committees (e.g. QIBA technical FDG PET/CT and Amyloid committees, member of EANM NeuroImaging  committee, EORTC imaging workgroup, EARL steering board). He is the principal author for the Netherlands and the European guidelines for standardisation of quantitative FDG PET and PET/CT studies (EJNMMI 2010 & 2015). Specialties: quantitative analysis of positron emission tomography studies; image processing, radiomics and artificial intelligence, image reconstruction, pharmacokinetic analysis (brain, onco, cardio),  PET standardization and QA and more recently Total Body PET/CT.
 

ANDREA CHINCARINI

"The added value of quantification for amyloid PET imaging" - March 14, 2022 at 2.15pm

Andrea Chincarini, PhD, physicist and researcher at the National Institute of Nuclear Physics, after a five-year post-graduate period in Germany and the United States, has been carrying out research in the field of gravitational wave detectors since the 2000s.
He mainly deals with mathematical models, data analysis, artificial intelligence and statistics applied in various fields of experimental physics which include, among other things, significant research in the field of neuroscience and medical physics.
He is currently local manager and member of the VIRGO Scientific Committee of the INFN VIRGO experiment, coordinator of the fifth National Scientific Commission and lecturer of the Gravitational Waves course (Master's degree curriculum in Physics) and at the School of Specialization in Medical Physics of the University of Studies of Genoa. He has been responsible for numerous Italian and European research projects and is a member of various scientific societies.
After earning a second doctorate - in Neuroscience - he founded a research group dedicated to the search for biomarkers in nuclear neurological imaging for the early and differential diagnosis of neurodegenerative diseases.
He is the author of more than 300 publications including works in international journals, monographs and books.


 

VALENTINA GARIBOTTO

"Elaborating a diagnostic algorithm : an intersocietal consensus" - March 15, 2022 at 11.45am

Pr. Valentina Garibotto is division chair of nuclear medicine and molecular imaging at the University Hospitals of Geneva and associate professor at the Geneva University. Her clinical and research experience focuses on imaging molecular targets, with a specific interest in neurodegenerative diseases.
 
Pr. Garibotto obtained her doctorate in medicine from the Genoa University Hospital in 2003, her specialization in nuclear medicine at the San Raffaele Hospital and Bicocca University in Milan in 2007 and the title of Privat Docent from the Geneva University in 2014. She has authored more than 190 peer reviewed articles (H index: 31, Scopus 18.11.2021) in the fields of clinical neuroimaging and nuclear medicine.
 
Her research group works on molecular imaging of neurodegenerative diseases, namely to characterize causative and protecting factors and to support the development of novel therapeutic approaches (
https://www.unige.ch/medecine/radio/en/groupes-de-recherche/984garibotto/ ). These research projects are mainly funded by the Swiss National Research foundation, the Velux Stiftung, the Schmidheiny and Aetas foundation.
 
She is Congress Chair Elected of the European Association of Nuclear Medicine, Chair of the Neuroimaging group of the Swiss Society of Nuclear Medicine and actively involved in a number of European initiatives fostering molecular imaging of cognitive disturbances, such as the European Alzheimer Disease Consortium PET, the European-Dementia with Lewy Body study group and the AMYPAD initiative.
She’s teaching molecular imaging at the pregraduate and postgraduate level in national and international courses.



 

ERIC GUEDJ

"Long COVID: PET demonstrated the brain dysfunctions" - March 15, 2022 at 8.45am

Eric GUEDJ is Professor of Biophysics and Nuclear Medicine at Aix-Marseille University, and head of the Department of Nuclear Medicine of Marseille University Hospital
He leads the scientific team IMOTHEP at Fresnel Institute (Aix-Marseille University, CNRS, Ecole Centrale) on the topic of biomarkers and theranostics for brain diseases
Eric GUEDJ is the coordinator of the group of nuclear physicians specialized in brain PET/SPECT imaging at the French National Society of Nuclear Medicine
He is a member of the Neuroimaging Committee at the European Association of Nuclear Medicine



 

JOLANTA KUNIKOWSKA

"PSMA theranostic for brain tumors: there is a world beyond the prostate" - March 14, 2022 at 1.45pm

Prof. Jolanta Kunikowska is a nuclear medicine as well as internal medicine physician specialist. She is currently professor at the Nuclear Medicine Department, Medical University, Warsaw/Poland. She has a broad interest in positron emission tomography (PET), molecular imaging applications in oncology and theragnostics (radionuclide therapy).  She has a particular interest in novel PET radiotracers, and theragnostic applications including prostate, neuroendocrine tumors and glioblastoma. She has authored over 100 peer-reviewed articles and several book chapters. She received several prestigious awards provided by various scientific communities including the Gold prize for Hisada award in 2018 and Marie Curie Award for outstanding scientific work presented at the 29th Annual Congress of the European Association of Nuclear Medicine (EANM) in Barcelona in 2016. She is currently a President of the EANM.



 

IAN LAW

"Total body PET/CT for the brain: what makes sense? " - March 14, 2022 at 10am

Ian Law is Professor at the University of Copenhagen, Denmark, and Chief Physician at the Dept of clinical physiology, nuclear medicine and PET, Rigshospitalet. He has written his Ph.D and habilitation thesis (DMSc) in PET perfusion imaging. Presently his primary research interests are clinical implementation and research use of PET/CT, PET/MRI, total body PET/CT with focus on neurooncology, neurodegeneration, and cerebrovascular disese.


               Share Share

New comment:

News | general information | Archives | Press Presse | Newsletters | DOCUMENTS